Market
Health & bioClear all
Lanes are never summed. Equity is Form D filings and matched press rounds; awards and exits will have their own sources.
Health & bio: subsectors
6 subsectors, sized by amount sold · 90 days to 2026-10-04 · as of 2026-10-0316 rounds not yet in a sector
16 rounds not yet in a sector
- ▲ Rising
- Steady
- Leaning (80%)
- ▼ Falling
- Quiet
Coloured by subsector state, 28 days to 2026-10-02 vs prior 28; shaded when the change is clear at 90% confidence, palest when only at 80%.
Equity · amount sold
Capital by week
Dollars sold per filing week, round count under each bar · 4 weeks to 2026-10-04 · as of 2026-10-03Stage mix
Inferred stage · 90 days to 2026-10-04 · as of 2026-10-03- Pre-seed123 roundsPre-seed rounds filed in the 90 days to 2026-10-04 · as of 2026-10-03How this is computed → · $157MAmount sold in original Pre-seed filings in the 90 days to 2026-10-04 · as of 2026-10-03How this is computed →
- Seed383 roundsSeed rounds filed in the 90 days to 2026-10-04 · as of 2026-10-03How this is computed → · $1.2BAmount sold in original Seed filings in the 90 days to 2026-10-04 · as of 2026-10-03How this is computed →
- Series A287 roundsSeries A rounds filed in the 90 days to 2026-10-04 · as of 2026-10-03How this is computed → · $3.7BAmount sold in original Series A filings in the 90 days to 2026-10-04 · as of 2026-10-03How this is computed →
- Series B88 roundsSeries B rounds filed in the 90 days to 2026-10-04 · as of 2026-10-03How this is computed → · $3.5BAmount sold in original Series B filings in the 90 days to 2026-10-04 · as of 2026-10-03How this is computed →
- Series C+84 roundsSeries C+ rounds filed in the 90 days to 2026-10-04 · as of 2026-10-03How this is computed → · $28.8BAmount sold in original Series C+ filings in the 90 days to 2026-10-04 · as of 2026-10-03How this is computed →
- Stage not inferred7 roundsStage not inferred rounds filed in the 90 days to 2026-10-04 · as of 2026-10-03How this is computed → · $1.0BAmount sold in original Stage not inferred filings in the 90 days to 2026-10-04 · as of 2026-10-03How this is computed →
Bar length is each stage’s share of the window’s rounds. Dollars of original filings only: an amendment’s restated amount counts in the map, not here. Stage is inferred from the amount sold, never stated on Form D; a stage named in a press release wins.
Where it landed
Which states the money was raised from, by the company's HQ · 90 days to 2026-10-04 · as of 2026-10-03- $0+
- $353M+
- $1.4B+
- $3.2B+
- $5.7B+
Mega-rounds shown separately (see the band above)
Rounds
Newest first · every row traces to a Form D on EDGAR or a matched press release · as of 2026-10-03| Company | Sector | Stage | Sold of offered | Filed | HQ | Exemption | Open roles | Hiring | Flags | |
|---|---|---|---|---|---|---|---|---|---|---|
| Altay TherapeuticsQuiet$15.7M of $45.1M · Series A · Health & bio · 506(b) · San Carlos, CA · 2026-10-02New | Altay TherapeuticsNew | Health & bio | Series A | $15.7M of $45.1MAmount sold of the amount offered on the filing of 2026-10-02 · as of 2026-10-03How this is computed → | 2026-10-02 | San Carlos, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | New |
| CarebilityQuiet$8.8M of $8.8M · Series A · Health & bio · 506(b) · Richardson, TX · 2026-10-02NewAI-native | CarebilityNewAI-native | Health & bio | Series A | $8.8M of $8.8MAmount sold of the amount offered on the filing of 2026-10-02 · as of 2026-10-03How this is computed → | 2026-10-02 | Richardson, TX | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | NewAI-native |
| CAD TherapeuticsQuiet$4.0M of $10.0M · Seed · Health & bio · 506(b) · New York, NY · 2026-10-02New | CAD TherapeuticsNew | Health & bio | Seed | $4.0M of $10.0MAmount sold of the amount offered on the filing of 2026-10-02 · as of 2026-10-03How this is computed → | 2026-10-02 | New York, NY | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | New |
| AlethiosQuiet$2.2M of $2.2M · Seed · Health & bio · 506(b) · San Francisco, CA · 2026-10-02New | AlethiosNew | Health & bio | Seed | $2.2M of $2.2MAmount sold of the amount offered on the filing of 2026-10-02 · as of 2026-10-03How this is computed → | 2026-10-02 | San Francisco, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | New |
| ALTIUS ORTHOPEDICS, INC.Quiet$2.1M of $2.4M · Seed · Health & bio · 506(b) · Logan, UT · 2026-10-02New | ALTIUS ORTHOPEDICS, INC.New | Health & bio | Seed | $2.1M of $2.4MAmount sold of the amount offered on the filing of 2026-10-02 · as of 2026-10-03How this is computed → | 2026-10-02 | Logan, UT | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | New |
| SmirtaQuiet$2.0M of $2.0M · Seed · Health & bio · 506(b), 4(a)(5) · Holmdel, NJ · 2026-10-02NewAI-native | SmirtaNewAI-native | Health & bio | Seed | $2.0M of $2.0MAmount sold of the amount offered on the filing of 2026-10-02 · as of 2026-10-03How this is computed → | 2026-10-02 | Holmdel, NJ | 506(b), 4(a)(5) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | NewAI-native |
| SiftwellHiring actively$1.6M of $2.5M · Seed · Health & bio · 506(b) · Charlotte, NC · 2026-10-02NewAI-native | SiftwellNewAI-native | Health & bio | Seed | $1.6M of $2.5MAmount sold of the amount offered on the filing of 2026-10-02 · as of 2026-10-03How this is computed → | 2026-10-02 | Charlotte, NC | 506(b) | 2The company's open roles on its careers page · as of 2026-10-03How this is computed → | Hiring actively | NewAI-native |
| PeerlogicHiring actively$1.2M of $1.5M · Pre-seed · Health & bio · 506(b) · Scottsdale, AZ · 2026-10-02NewAI-native | PeerlogicNewAI-native | Health & bio | Pre-seed | $1.2M of $1.5MAmount sold of the amount offered on the filing of 2026-10-02 · as of 2026-10-03How this is computed → | 2026-10-02 | Scottsdale, AZ | 506(b) | 5The company's open roles on its careers page · as of 2026-10-03How this is computed → | Hiring actively | NewAI-native |
| Click TherapeuticsQuiet$50.0M of $50.0M · Series B · Health & bio · 506(b) · New York, NY · 2026-10-01New | Click TherapeuticsNew | Health & bio | Series B | $50.0M of $50.0MAmount sold of the amount offered on the filing of 2026-10-01 · as of 2026-10-03How this is computed → | 2026-10-01 | New York, NY | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | New |
| Amani TherapeuticsQuiet$35.0M of $60.0M · Series B · Health & bio · 506(b) · New York, NY · 2026-10-01New | Amani TherapeuticsNew | Health & bio | Series B | $35.0M of $60.0MAmount sold of the amount offered on the filing of 2026-10-01 · as of 2026-10-03How this is computed → | 2026-10-01 | New York, NY | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | New |
| BiotiaQuiet$9.0M · Series A · Health & bio · New York City, NY · 2026-10-01New | BiotiaNew | Health & bio | Series A | $9.0MAmount sold on the filing of 2026-10-01 · as of 2026-10-03How this is computed → | 2026-10-01 | New York City, NY | — | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | New |
| Solaris EndovascularQuiet$5.0M of $10.0M · Seed · Health & bio · 506(b) · Dallas, TX · 2026-10-01NewUndersubscribed | Solaris EndovascularNewUndersubscribed | Health & bio | Seed | $5.0M of $10.0MAmount sold of the amount offered on the filing of 2026-10-01 · as of 2026-10-03How this is computed → | 2026-10-01 | Dallas, TX | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | NewUndersubscribed |
| Penelope HealthHiring actively$25.0M of $25.0M · Series A · Health & bio · 506(b) · Dover, DE · 2026-09-30NewAI-native | Penelope HealthNewAI-native | Health & bio | Series A | $25.0M of $25.0MAmount sold of the amount offered on the filing of 2026-09-30 · as of 2026-10-03How this is computed → | 2026-09-30 | Dover, DE | 506(b) | 5The company's open roles on its careers page · as of 2026-10-03How this is computed → | Hiring actively | NewAI-native |
| Huxley MedicalQuiet$11.0M of $11.7M · Series A · Health & bio · 506(b) · Atlanta, GA · 2026-09-30New | Huxley MedicalNew | Health & bio | Series A | $11.0M of $11.7MAmount sold of the amount offered on the filing of 2026-09-30 · as of 2026-10-03How this is computed → | 2026-09-30 | Atlanta, GA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | New |
| GenHealth.aiHiring actively$16.5M of $16.5M · Series A · Health & bio · 506(b) · Vienna, VA · 2026-09-29NewAI-native | GenHealth.aiNewAI-native | Health & bio | Series A | $16.5M of $16.5MAmount sold of the amount offered on the filing of 2026-09-29 · as of 2026-10-03How this is computed → | 2026-09-29 | Vienna, VA | 506(b) | 13The company's open roles on its careers page · as of 2026-10-03How this is computed → | Hiring actively | NewAI-native |
| VETmAb BiosciencesQuiet$11.4M of $11.9M · Series A · Health & bio · 506(b) · San Diego, CA · 2026-09-29New | VETmAb BiosciencesNew | Health & bio | Series A | $11.4M of $11.9MAmount sold of the amount offered on the filing of 2026-09-29 · as of 2026-10-03How this is computed → | 2026-09-29 | San Diego, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | New |
| Sialia Therapeutics, Inc.Quiet$1.5M of $1.5M · Seed · Health & bio · 506(b) · Irvine, CA · 2026-09-29New | Sialia Therapeutics, Inc.New | Health & bio | Seed | $1.5M of $1.5MAmount sold of the amount offered on the filing of 2026-09-29 · as of 2026-10-03How this is computed → | 2026-09-29 | Irvine, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | New |
| Precision NeuroscienceQuiet$250M · Series D · Health & bio · 506(b) · New York, NY · 2026-09-28New | Precision NeuroscienceNew | Health & bio | Series D | $250MAmount sold on the filing of 2026-09-28 · as of 2026-10-03How this is computed → | 2026-09-28 | New York, NY | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | New |
| ALPFA MedicalQuiet$80.3M of $100M · Series C+ · Health & bio · 506(b) · Palo Alto, CA · 2026-09-28New | ALPFA MedicalNew | Health & bio | Series C+ | $80.3M of $100MAmount sold of the amount offered on the filing of 2026-09-28 · as of 2026-10-03How this is computed → | 2026-09-28 | Palo Alto, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | New |
| Paradigm HealthQuiet$31.1M of $56.1M · Series B · Health & bio · 506(b) · Palo Alto, CA · 2026-09-28NewAI-native | Paradigm HealthNewAI-native | Health & bio | Series B | $31.1M of $56.1MAmount sold of the amount offered on the filing of 2026-09-28 · as of 2026-10-03How this is computed → | 2026-09-28 | Palo Alto, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | NewAI-native |
| Xact BioQuiet$10.0M of $18.0M · Series A · Health & bio · 506(b) · Boston, MA · 2026-09-28New | Xact BioNew | Health & bio | Series A | $10.0M of $18.0MAmount sold of the amount offered on the filing of 2026-09-28 · as of 2026-10-03How this is computed → | 2026-09-28 | Boston, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | New |
| Evia BioQuiet$5.5M of $5.5M · Seed · Health & bio · 506(b) · Minneapolis, MN · 2026-09-28New | Evia BioNew | Health & bio | Seed | $5.5M of $5.5MAmount sold of the amount offered on the filing of 2026-09-28 · as of 2026-10-03How this is computed → | 2026-09-28 | Minneapolis, MN | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | New |
| Navigator MedicinesQuiet$10.0M of $40.0M · Series A · Health & bio · 506(b) · San Mateo, CA · 2026-09-25 | Navigator Medicines | Health & bio | Series A | $10.0M of $40.0MAmount sold of the amount offered on the filing of 2026-09-25 · as of 2026-10-03How this is computed → | 2026-09-25 | San Mateo, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | |
| Aseko, Inc.Quiet$10.0M of $10.0M · Series A · Health & bio · 506(b) · Atlanta, GA · 2026-09-25 | Aseko, Inc. | Health & bio | Series A | $10.0M of $10.0MAmount sold of the amount offered on the filing of 2026-09-25 · as of 2026-10-03How this is computed → | 2026-09-25 | Atlanta, GA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | |
| OptoVista Holdings, LLCQuiet$3.7M of $3.7M · Seed · Health & bio · 506(c) · Washington, DC · 2026-09-25 | OptoVista Holdings, LLC | Health & bio | Seed | $3.7M of $3.7MAmount sold of the amount offered on the filing of 2026-09-25 · as of 2026-10-03How this is computed → | 2026-09-25 | Washington, DC | 506(c) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | |
| Modern Medical Holdings, IncQuiet$3.0M of $6.0M · Seed · Health & bio · 506(b) · Winter Garden, FL · 2026-09-25Undersubscribed | Modern Medical Holdings, IncUndersubscribed | Health & bio | Seed | $3.0M of $6.0MAmount sold of the amount offered on the filing of 2026-09-25 · as of 2026-10-03How this is computed → | 2026-09-25 | Winter Garden, FL | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | Undersubscribed |
| WayBioQuiet$2.0M of $2.0M · Seed · Health & bio · 506(b) · Cambridge, MA · 2026-09-25 | WayBio | Health & bio | Seed | $2.0M of $2.0MAmount sold of the amount offered on the filing of 2026-09-25 · as of 2026-10-03How this is computed → | 2026-09-25 | Cambridge, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | |
| EnteroTrackHiring actively$2.0M of $2.0M · Seed · Health & bio · 506(b) · Aurora, CO · 2026-09-25 | EnteroTrack | Health & bio | Seed | $2.0M of $2.0MAmount sold of the amount offered on the filing of 2026-09-25 · as of 2026-10-03How this is computed → | 2026-09-25 | Aurora, CO | 506(b) | 2The company's open roles on its careers page · as of 2026-10-03How this is computed → | Hiring actively | |
| AutoIVFQuiet$1.5M of $1.5M · Seed · Health & bio · 506(b) · Natick, MA · 2026-09-25 | AutoIVF | Health & bio | Seed | $1.5M of $1.5MAmount sold of the amount offered on the filing of 2026-09-25 · as of 2026-10-03How this is computed → | 2026-09-25 | Natick, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | |
| SeraxisQuiet$10.0M of $10.0M · Series A · Health & bio · 506(b) · Germantown, MD · 2026-09-24 | Seraxis | Health & bio | Series A | $10.0M of $10.0MAmount sold of the amount offered on the filing of 2026-09-24 · as of 2026-10-03How this is computed → | 2026-09-24 | Germantown, MD | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | |
| AngelEye HealthQuiet$10.0M of $20.0M · Series A · Health & bio · 506(b) · Nashville, TN · 2026-09-24 | AngelEye Health | Health & bio | Series A | $10.0M of $20.0MAmount sold of the amount offered on the filing of 2026-09-24 · as of 2026-10-03How this is computed → | 2026-09-24 | Nashville, TN | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | |
| Acuitive TechnologiesQuiet$1.9M of $3.0M · Seed · Health & bio · 506(b) · Allendale, NJ · 2026-09-24 | Acuitive Technologies | Health & bio | Seed | $1.9M of $3.0MAmount sold of the amount offered on the filing of 2026-09-24 · as of 2026-10-03How this is computed → | 2026-09-24 | Allendale, NJ | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | |
| Basecamp ResearchQuiet$140M · Series C · Health & bio · London · 2026-09-23AI-native | Basecamp ResearchAI-native | Health & bio | Series C | $140MAmount sold on the filing of 2026-09-23 · as of 2026-10-03How this is computed → | 2026-09-23 | London | — | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | AI-native |
| Basecamp ResearchQuiet$140M · Series C · Health & bio · London · 2026-09-23AI-native | Basecamp ResearchAI-native | Health & bio | Series C | $140MAmount sold on the filing of 2026-09-23 · as of 2026-10-03How this is computed → | 2026-09-23 | London | — | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | AI-native |
| Caspian TherapeuticsQuiet$50.0M of $50.0M · Series B · Health & bio · 506(b) · San Diego, CA · 2026-09-23 | Caspian Therapeutics | Health & bio | Series B | $50.0M of $50.0MAmount sold of the amount offered on the filing of 2026-09-23 · as of 2026-10-03How this is computed → | 2026-09-23 | San Diego, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | |
| BioInsightsQuiet$2.7M of $7.9M · Seed · Health & bio · 506(b) · Lutz, FL · 2026-09-22AI-native | BioInsightsAI-native | Health & bio | Seed | $2.7M of $7.9MAmount sold of the amount offered on the filing of 2026-09-22 · as of 2026-10-03How this is computed → | 2026-09-22 | Lutz, FL | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | AI-native |
| Navion Neurosciences Inc.Quiet$1.9M of $5.1M · Seed · Health & bio · 506(b) · Charlottesville, VA · 2026-09-22Undersubscribed | Navion Neurosciences Inc.Undersubscribed | Health & bio | Seed | $1.9M of $5.1MAmount sold of the amount offered on the filing of 2026-09-22 · as of 2026-10-03How this is computed → | 2026-09-22 | Charlottesville, VA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | Undersubscribed |
| Typewriter TherapeuticsHiring actively$56.3M of $56.3M · Series B · Health & bio · 506(b) · Cambridge, MA · 2026-09-21 | Typewriter Therapeutics | Health & bio | Series B | $56.3M of $56.3MAmount sold of the amount offered on the filing of 2026-09-21 · as of 2026-10-03How this is computed → | 2026-09-21 | Cambridge, MA | 506(b) | 1The company's open roles on its careers page · as of 2026-10-03How this is computed → | Hiring actively | |
| Avery TherapeuticsQuiet$8.5M of $15.4M · Series A · Health & bio · 506(b) · Tucson, AZ · 2026-09-21 | Avery Therapeutics | Health & bio | Series A | $8.5M of $15.4MAmount sold of the amount offered on the filing of 2026-09-21 · as of 2026-10-03How this is computed → | 2026-09-21 | Tucson, AZ | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet | |
| 3HelixQuiet$7.8M of $10.0M · Series A · Health & bio · 506(b) · Salt Lake City, UT · 2026-09-21 | 3Helix | Health & bio | Series A | $7.8M of $10.0MAmount sold of the amount offered on the filing of 2026-09-21 · as of 2026-10-03How this is computed → | 2026-09-21 | Salt Lake City, UT | 506(b) | 0The company's open roles on its careers page · as of 2026-10-03How this is computed → | Quiet |